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Abstract
Background: Metabolic disorders presenting in HIV-infected patients on antiretroviral therapy (ART) may increase
the risk of osteoarthritis. However, structural changes of the knee in HIV infected subjects are understudied. The aim
of this study is to investigate knee cartilage degeneration and knee structural changes over 8 years in subjects with
and without HIV infection determined based on the use of ART.
Methods: We studied 10 participants from the Osteoarthritis Initiative who received ART at baseline and 20
controls without ART, frequency matched for age, sex, race, baseline body mass index (BMI) and Kellgren &
Lawrence grade. Knee abnormalities were assessed using the whole-organ magnetic resonance imaging score
(WORMS) and cartilage T2 including laminar and texture analyses were analyzed using a multislice-multiecho spin-
echo sequence. Signal abnormalities of the infrapatellar fat pad (IPFP) and suprapatellar fat pad (SPFP) were
assessed separately using a semi-quantitative scoring system. Linear regression models were used in the cross-
sectional analysis to compare the differences between ART/HIV subjects and controls in T2 (regular and laminar T2
values, texture parameters) and morphologic parameters (subscores of WORMS, scores for signal alterations of IPFP
and SPFP). Mixed effects models were used in the longitudinal analysis to compare the rate of change in T2 and
morphological parameters between groups over 8 years.
Results: At baseline, individuals on ART had significantly greater size of IPFP signal abnormalities (P = 0.008), higher signal
intensities of SPFP (P = 0.015), higher effusion scores (P = 0.009), and lower subchondral cysts sum scores (P = 0.003)
compared to the controls. No significant differences were found between the groups in T2-based cartilage parameters
and WORMS scores for cartilage, meniscus, bone marrow edema patterns and ligaments (P > 0.05). Longitudinally, the HIV
cohort had significantly higher global knee T2 entropy values (P = 0.047), more severe effusion (P = 0.001) but less severe
subchondral cysts (P = 0.002) on average over 8 years.
Conclusions: Knees of individuals with HIV on ART had a more heterogeneous cartilage matrix, more severe synovitis
and abnormalities of the IPFP and SPFP, which may increase the risk of incident knee osteoarthritis.
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Background
Since the introduction and constant optimization of
antiretroviral therapy (ART), the life expectancy of
people living with HIV (PLWH) has increased signifi-
cantly over the past decades and is now similar to or ap-
proaching that of an HIV-negative person [1]. However,
the direct or indirect consequences of immunodefi-
ciency, chronic inflammatory status and cumulative
toxic effects of ART, aging patients with HIV infection
are reported to have increased risk for “non-AIDS” co-
morbidities such as cardiovascular diseases, neurocogni-
tive diseases, liver and kidney diseases, metabolic
syndrome (MetS), cancers and rheumatic diseases [1–4].
With the increasing life expectancy of PLWH, the im-
pact of these “non-AIDS” comorbidities are gaining clin-
ical significance [5].
Osteoarthritis (OA) is one of the most common rheum-
atological disorders, which affects 240 million people glo-
bally and 27 million people in the USA [6, 7]. Although
aging remains the most important risk factor for OA,
MetS, which is a combination of hypertension, dyslipid-
emia, diabetes (or insulin resistance) and abdominal obes-
ity, may also play an essential role in the occurrence and
development of OA [8]. MetS also affects up to half of
HIV-infected patients receiving ART [9]. While studies
have reported an increased prevalence and severity of
radiographic hand osteoarthritis in patients with HIV-1
infection, in particular associated with MetS, the exact
pathophysiology of OA in PLWH is not well understood
[10, 11]. Studies have reported more heterogeneous cartil-
age T2 relaxation times in diabetics, indicating increased
articular cartilage degeneration [12, 13]. The detrimental
impact of dyslipidemia, obesity and MetS-associated
chronic low-grade inflammation on cartilage metabolism
have also been demonstrated [8, 14, 15].
A recent cross-sectional study [16] suggested that tib-
ial cartilage volume of HIV-infected patients was re-
duced and associated with increased central fat
accumulation, which may potentially influence the sub-
sequent development of knee OA. However, there is lim-
ited knowledge about the association of HIV/ART with
knee OA. In particular, little is known how HIV and
ART affect the composition of knee cartilage and how
they affect the severity and progression of knee OA.
Torshizy et al. [17] and Petscavage et al. [18] described
MR imaging signal alterations of the infrapatellar fat pad
(IPFP) and the suprapatellar fat pad (SPFP) in PLWH
with non-specific knee pain, that was characterized by
global homogeneous increase in signal throughout IPFP
or SPFP on fluid sensitive sequences. The IPFP, also
known as Hoffa’s fat pad, not only plays a role in absorb-
ing mechanical force generated by joint movement but
affects the occurrence and development of knee OA by
producing and releasing important inflammatory
mediators [19]. Several studies [20–24] have reported
that signal intensity alterations of the IPFP and the SPFP
are important imaging biomarkers for knee OA. In the
setting of HIV, however, it is not known whether and
how signal alteration within the IPFP and SPFP change
over time and whether it increases the risk of OA in
HIV-infected patients.
Thus, the purpose of our study was to evaluate knee
joint health in individuals with HIV treated with ART
using quantitative and structural MRI-based parameters
and compare these with matched controls using a longi-
tudinal study design.
Methods
Database and subjects
This study utilized data from the Osteoarthritis Initiative
cohort (OAI, https://oai.nih.gov), a longitudinal,
multi-center cohort study which recruited 4796 individ-
uals and is sponsored by the US National Institutes of
Health (NIH). The aim of the OAI was to develop a
large database to study the natural progression, risk fac-
tors and predictors of knee OA. The study protocol,
amendments, and informed consent documentation
were reviewed and approved by all local institutional re-
view boards. Information about specific OAI datasets
that we used are described in Additional file 1.
Subjects with HIV infection were identified based on
the use of typical HIV ART combinations at baseline as
recorded in the baseline medication inventory, a data-
base of prescription medications taken by participants in
the past 30 days (Additional file 2). Inclusion criteria re-
quired subjects in the HIV cohort to be on ART regime
for at least one year and for control subjects to not take
any type of antiretroviral medications during the
follow-up period. HIV subjects were frequency matched
with control subjects 1:2 for age, sex, race, baseline body
mass index (BMI) and Kellgren-Lawrence (K&L) grades.
Categories for the matching were defined by combin-
ation of: sex (male or female), K&L grade (0, 1, 2, 3, 4),
age (5 year intervals), BMI (2.5 kg/m2 intervals) and race
(White or Caucasian, Black or African American). Indi-
viduals with a history of rheumatoid arthritis were
excluded.
MR imaging protocol
MR images were obtained at four different clinical sites
of the OAI with cross calibrated 3.0-T scanners (Magne-
tom Trio, Siemens, Erlangen, Germany) using identical
quadrature transmit-receive coils (USA Instruments,
Aurora, Ohio). To semi-quantitatively assess structural
abnormalities of bilateral knees three sequences were
used: (a) coronal 2D intermediate-weighted (IW) turbo
spin-echo (TSE) sequence (repetition time [TR]/echo
time [TE] = 3700/29 ms), (b) sagittal 3D dual-echo
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steady-state (DESS) sequence with water excitation and
coronal and axial reformations (TR/TE = 16.3/4.7 ms,
flip angle = 25°) and (c) sagittal 2D IW fat-suppressed
TSE sequence (TR/TE = 3200/30 ms).
Quantitative measurements based on T2 relaxation
time were obtained of the right knee using a sagittal 2D
multislice multiecho (MSME) spin-echo (SE) sequence
(TR = 2700 ms, TEs = 10, 20, 30, 40, 50, 60 and 70ms,
field of view = 12 cm, slice thickness = 3 mm with 0.5
mm gap, in-plane spatial resolution = 0.31 × 0.45 mm2).
This sequence was only performed at the right knee.
Additional information about the above sequences are
available in the OAI MR protocol [25].
MR image analysis
Semi-quantitative morphological analysis
All available images of both left and right knees at baseline
and annual follow-up timepoints (12-months, 24-months,
36-months, 48-months, 72-months, 96-months; the num-
bers of participants with available images at each time
point are summarized in Additional file 3) of HIV subjects
and controls were assessed by one radiologist (Y.L. 4 years
of experience) blinded to subject characteristics and under
supervision of a board certified musculoskeletal radiolo-
gist (T.M.L. 24 years of experience). The modified
WORMS [26] was used for semi-quantitative analysis of
OA-related abnormalities. The following parameters were
evaluated separately: meniscal lesions were graded from 0
to 5 in each of 6 regions (medial/lateral and anterior/
body/posterior); cartilage defects were graded from 0 to 6,
bone marrow edema pattern (BMEP) as well as subarticu-
lar cysts were scored from 0 to 3 in each of 6 regions (pa-
tella, trochlea, medial/lateral femur, and medial/lateral
tibia). Other lesions including ligamentous abnormalities
and joint effusion were also scored. Moreover, we calcu-
lated sum scores for each imaging parameter individually
over all sub-regions of each knee.
T2 relaxation time measurements
The software used for the T2 analysis was developed
at our institution and is a spline-based algorithm
written in MATLAB (the Mathworks, Natick, Massa-
chusetts), that has been described previously [13].
The cartilage of five compartments (patella, lateral
femur, medial femur, lateral tibia, medial tibia) was
semi-automatically segmented. The trochlear region
was excluded from the analysis due to flow-artifacts
caused by the popliteal artery. Mean T2 values of the
baseline and available follow-up timepoints were com-
puted separately for each compartment and globally
(average of all compartments combined) of the seg-
mented regions of interest.
Laminar and GLCM texture analysis
Laminar and gray level co-occurrence matrix (GLCM)
texture analyses were performed to characterize the
spatial distribution of cartilage T2 values for each com-
partment (patella, lateral femur, medial femur, lateral
tibia, medial tibia) and the whole knee joint (the mean
was calculated across all compartments). Laminar ana-
lysis can reveal early laminar disruption within cartilage
when mean T2 does not yet show changes of cartilage
composition [12, 13]. In the laminar analysis, the cartil-
age in each compartment was split into two layers with
approximately the same thickness, a deep layer adjacent
to the bone-cartilage interface (referred to as the bone
layer) and an articular superficial layer (referred to as
the articular layer). For GLCM texture analysis, contrast,
variance, and entropy were computed to measure the ex-
tent of heterogeneity of T2 values within the cartilage
matrix, which has been used to detect compositional
changes of cartilage before changes of regular T2 values
is present [13, 27]. Contrast characterizes the differences
of grey levels between each pixel and its neighboring
pixels with elevated T2 contrast demonstrating higher
differences and more heterogeneity. Variance assesses
the distribution of pixels about the mean, indicating how
many pixels vary from the average compartment grey
level. Entropy measures the disorder in an image, with
high entropy values suggesting less uniform distributions
of probabilities of T2 value co-occurrences.
IPFP and SPFP signal abnormalities analysis
Using sagittal 2D IW fat-suppressed TSE sequences,
two radiologists (T.M.L. and Y.L.) assessed the size
and highest signal intensity of IPFP signal abnormal-
ities and the highest signal intensity of SPFP signal
abnormalities (due to the small volume of the SPFP,
the size of signal abnormalities was not assessed).
The size of IPFP signal abnormalities was graded as
follows: grade 0 = none; grade 1 ≤ 33% of the region;
grade 2 = 34–66% of the region; grade 3 ≥ 66% of the
region; while the highest signal intensity was charac-
terized as follows: grade 0 = none; grade 1 = mild
(lower than cartilage); grade 2 =moderate (equal to or
higher than cartilage but lower than fluid); grade 3 = severe
(equal to fluid).
Intra- / inter-reader reproducibility
Reproducibility results of the WORMS grading and the
knee cartilage T2 relaxation time measurements have
been described and validated by our group in multiple
previous studies [12, 13, 26, 28]. For WORMS readings,
the intra-class correlation coefficients (ICCs) for intrar-
eader agreement ranged from 0.85 to 0.98 for meniscus
and 0.84 to 0.97 for cartilage, and ICCs for inter-reader
agreement ranged from 0.83 to 0.95 for meniscus and
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0.80 to 0.92 for cartilage. For reproducibility of cartilage
T2 measurements, coefficients of variation (CV) were
calculated on a percentage basis as the root mean square
average, with CVs ranging from 1.66 to 1.76% for intrar-
eader agreement and 1.12 to 2.06% for inter-reader
agreement.
Reproducibility for IPFP and SPFP gradings were
assessed in 10 randomly selected subjects. Each score of
the gradings was graded twice by two radiologists
(T.M.L. and Y.L.) on two separate occasions with a sep-
aration of 4 weeks in between those two readings. Ob-
served agreement and Weighted Cohen’s Kappa values
were calculated to compare each score separately.
Intra-reader observed agreement/kappa values were
95%/0.87 and 88%/0.64 for the size of IPFP signal abnor-
malities, 95%/0.86 and 85%/0.55 for the highest signal
intensity of IPFP signal abnormalities, 95%/0.77 and
90%/0.00 (the observed agreement and chance agree-
ment were equal) for highest signal intensity of SPFP
signal abnormalities. Inter-reader observed agreement/
kappa values were 98%/0.94 for the size of IPFP signal
abnormalities, 93%/0.80 for the highest signal intensity
of IPFP signal abnormalities and 95%/0.77 for the high-
est signal intensity of signal abnormalities within SPFP.
Statistical analysis
Statistical analyses were performed with STATA version
14 software (StataCorp LP, College Station, TX), using a
two-sided, 0.05 level of significance. The differences in
baseline subject characteristics between groups were
assessed using Student’s independent t-tests (continuous
variables) and chi-square tests (categorical variables). For
the cross-sectional analysis, linear regression models
were used to assess the differences between ART/HIV
subjects and controls in T2 (regular and laminar T2
values, GLCM texture parameters) and morphologic pa-
rameters (subscores of WORMS, scores for signal alter-
ations of IPFP and SPFP). Mixed effects models were
used in the longitudinal analysis to compare the rate of
change in T2 and morphological parameters between
groups over 8 years by testing for an interaction between
time and HIV group. For the differences in the rates of
change over time, we first tested for non-linearity by in-
cluding an interaction between time [quadratic] and
HIV group. If the quadratic time term was significant (P
< 0.05), then we used a quadratic, non-linear model with
an interaction between quadratic time and HIV group. If
quadratic time term was not significant then we used
time [linear] interaction with HIV group in the model. If
there were no significant interactions of HIV group with
time (P > 0.05) we tested whether there were significant
differences in T2 and morphological parameters aver-
aged over all timepoints. All analyses were adjusted for
baseline age, sex, race, baseline BMI and K&L grades.
Based on results from previous studies [12, 13], we
considered T2-based knee cartilage parameters (cartil-
age T2 values, laminar T2 values and GLCM texture
parameters) as primary outcome measures, while
other morphological parameters (cartilage damage,
meniscus lesions, BMEPs, subchondral cysts, effusion
and ligamentous abnormalities) and signal abnormal-
ities of IPFP and SPFP were considered exploratory
outcome parameters.
Results
Our sample consisted of 10 subjects in the ART/HIV
group and 20 subjects in the control group (30% female,
mean baseline age 52.1 ± 6.2 years, mean baseline BMI
27.6 ± 3.7 kg/m2). As expected, based on frequency
matching, no significant differences were noted for age,
sex, race, and baseline BMI and K&L grades between
subjects with and without HIV infection (Table 1).
Primary outcome parameters
Cartilage matrix composition
At baseline, global overall T2 values, global T2 values of
bone and articular layer as well as all global T2 texture
parameters (contrast, variance, and entropy) were
slightly higher in the HIV group compared to the control
group, but no significant differences were observed
(Table 2).
The interaction between time and the HIV group was sig-
nificant for the texture parameters global knee contrast and
variance (Table 3). On average over all timepoints, global
knee entropy values were significantly higher in the HIV
group compared to the control group (P = 0.047, Fig. 1a).
Global T2 values (P = 0.809, Fig. 1b), global T2 values of
bone layer (P = 0.669) and articular layer (P = 0.180) were
slightly higher on average over all timepoints in the HIV
group but not significantly (p > 0.05).
Exploratory outcome parameters
Knee morphological changes
At baseline, the HIV group had significantly lower sub-
chondral cysts WORMS sum scores and significantly
higher effusion WORMS scores (P = 0.003 and P = 0.009
respectively, Table 2). No differences were observed be-
tween groups in WORMS sum scores for cartilage, me-
niscus, BMEPs and ligaments.
The interaction between time and the HIV group was
not significant for all morphological parameters assessed
based on WORMS (Table 3). On average over all time-
points, subchondral cysts sum scores were found to be
significantly lower in PLWH (P = 0.002, Fig. 2a), while
effusion scores were significantly higher compared to
controls (P = 0.001, Fig. 2b). The WORMS sum scores
for cartilage, meniscus, BMEPs and ligaments were not
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Table 1 Subject characteristics at baseline
All subjects (n = 30) HIV group (n = 10) Control group (n = 20) P valuea
Age, mean ± SD years 52.1 ± 6.2 52.2 ± 6.9 52.0 ± 6.0 0.940
Females [n (%)]/Males [n (%)] 9 (30%) / 21 (70%) 3 (30%) / 7 (70%) 6 (30%) / 14 (70%) 1.000
BMI, mean ± SD kg/m2 27.6 ± 3.7 27.4 ± 3.6 27.7 ± 3.8 0.831
Knee Kellgren-Lawrence scores 1.000
Grade 0 [n (%)] 27 (45%) 9 (45%) 18 (45%)
Grade 1 [n (%)] 12 (20%) 4 (20%) 8 (20%)
Grade 2 [n (%)] 15 (25%) 5 (25%) 10 (25%)
Grade 3 [n (%)] 6 (10%) 2 (10%) 4 (10%)
Racial composition 1.000
White or Caucasian [n (%)] 12 (40%) 4 (40%) 8 (40%)
Black or African American [n (%)] 18 (60%) 6 (60%) 12 (60%)
Continuous data were expressed as mean ± SD. Categorical data were presented in numbers of participants with percentage in parentheses. a P-values were
calculated using either Pearson’s χ2-test or independent t-test as appropriate
Table 2 Results of baseline analyses for primary and exploratory outcome parameters between groups
Parameters Control group (n = 20) HIV group (n = 10) Effect size
(95% CI)b
P value
Adjusted meansa Adjusted meansa
Primary outcome parameters
Regular T2 values
Global knee T2 32.71 ± 0.43 32.90 ± 0.60 0.19 (−1.35, 1.73) 0.801
Laminar T2 values
Global bone layer T2 29.92 ± 0.37 30.14 ± 0.52 0.22 (− 1.10, 1.54) 0.737
Global articular layer T2 34.85 ± 0.50 36.03 ± 0.71 1.17 (−0.62, 2.97) 0.188
Texture parameters
Global knee contrast 304.98 ± 16.45 307.59 ± 23.27 2.61 (− 56.39, 61.61) 0.928
Global knee variance 223.60 ± 11.76 224.22 ± 16.64 0.61 (−41.57, 42.79) 0.976
Global knee entropy 6.29 ± 0.04 6.40 ± 0.05 0.11 (− 0.03, 0.25) 0.124
Exploratory outcome parameters
WORMS scores
Cartilage sum score 4.15 ± 0.49 3.15 ± 0.69 −1.00 (− 2.65, 0.66) 0.238
Meniscus sum score 2.58 ± 0.44 1.68 ± 0.62 −0.90 (− 2.40, 0.60) 0.241
BMEPs sum score 2.60 ± 0.38 1.86 ± 0.53 −0.74 (− 2.02, 0.54) 0.260
Subchondral cysts sum score 2.15 ± 0.30 0.65 ± 0.42 −1.51 (−2.51, −0.50) 0.003
Effusion score 0.05 ± 0.04 0.25 ± 0.06 0.20 (0.05, 0.35) 0.009
Ligament sum score 0.45 ± 0.15 0.31 ± 0.21 −0.14 (−0.66, 0.37) 0.590
IPFP and SPFP signal abnormalities
IPFP signal abnormalities (size) 0.78 ± 0.13 1.39 ± 0.19 0.62 (0.16, 1.07) 0.008
IPFP signal abnormalities (SI) 1.30 ± 0.17 1.55 ± 0.24 0.24 (−0.34, 0.83) 0.409
SPFP signal abnormalities (SI) 1.35 ± 0.11 1.80 ± 0.16 0.45 (0.09, 0.81) 0.015
a adjusted means were expressed as mean ± SD. b effect size for difference in each parameter between groups, with (95% confidence intervals, CI) provided.
Adjusted means and effect size were corrected for age, sex, race and baseline BMI and K&L grades. P values < 0.05 were in bold, indicating significant difference
between two groups in corresponding score. BMEP bone marrow edema pattern, IPFP infrapatellar fat pad, SPFP suprapatellar fat pad, SI signal intensity
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Table 3 Results of longitudinal analyses for primary and exploratory outcome parameters between groups
Parameters The rates of change over 8 years Differences on average over 8 years
Effect size (95% CI)a Pi value Effect size (95% CI)
b Pa value
Primary outcome parameters
Regular T2 values
T2 global* 0.005 (−0.011, 0.022) 0.523 0.13 (−0.90, 1.15) 0.809
Laminar T2 values
Global bone layer T2 0.006 (−0.009, 0.022) 0.411 0.20 (−0.72, 1.12) 0.669
Global articular layer T2 0.005 (−0.014, 0.024) 0.620 0.89 (−0.41, 2.19) 0.180
Texture parameters
Global knee contrast* −0.072 (−0.108, − 0.035) 0.000
Global knee variance* −0.031 (− 0.050, − 0.013) 0.001
Global knee entropy* −0.001 (− 0.004, 0.002) 0.460 0.09 (0.00, 0.19) 0.047
Exploratory outcome parameters
WORMS scores
Cartilage sum score 0.012 (−0.008, 0.032) 0.248 −1.04 (−2.61, 0.53) 0.194
Meniscus sum score 0.004 (−0.008, 0.015) 0.514 −0.79 (− 2.31, 0.74) 0.313
BMEPs sum score 0.004 (−0.006, 0.015) 0.437 −0.89 (−2.21, 0.43) 0.188
Subchondral cysts sum score 0.001 (−0.009, 0.012) 0.788 −1.51 (−2.47, − 0.55) 0.002
Effusion score 0.000 (−0.003, 0.003) 0.865 0.24 (0.10, 0.38) 0.001
Ligament sum score* −0.001 (− 0.007, 0.004) 0.610 − 0.16 (− 0.65, 0.34) 0.534
IPFP and SPFP signal abnormalities
IPFP signal abnormalities (size) −0.007 (− 0.011, − 0.003) 0.001
IPFP signal abnormalities (SI) −0.006 (− 0.011, − 0.002) 0.010
SPFP signal abnormalities (SI)* −0.004 (− 0.007, − 0.000) 0.030
*Parameters that had a non-linear change over 8 years. aEffect size for the rates of change over 8 years between groups, with (95% confidence intervals, CI)
provided. bEffect size for the differences on average over 8 years between groups, with (95% confidence intervals) provided. Effect size were corrected for age,
sex, race and baseline BMI and K&L grades. Pi values < 0.05 were in bold, indicating significant interactions with time. Pa values < 0.05 were in bold, indicating
significant differences on average over 8 years. BMEP bone marrow edema pattern, IPFP infrapatellar fat pad, SPFP suprapatellar fat pad, SI signal intensity
Fig. 1 Changes in global entropy and global T2 values during the 96-month follow-up. a Changes in global entropy values over 96 months. b
Changes in global knee T2 values over 96 months. Data were given as adjusted means, corrected for age, sex, race and baseline BMI and K&L
grades. Error bars represented standard errors. P-values in bold refer to significant differences between groups on average over 8 years,
respectively: global T2 entropy (P = 0.047), global T2 (P = 0.809)
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significantly different on average over all time points be-
tween groups.
IPFP and SPFP signal abnormalities
The baseline scores for the size of IPFP signal abnor-
malities and the signal intensity scores of the SPFP
were significantly higher in the HIV group (P = 0.008
and P = 0.015 respectively, Table 2). The signal inten-
sity scores of the IPFP were also higher in HIV
cohort, however, this was not statistically significant
(P = 0.409). At baseline, two out of the ten HIV sub-
jects had a diffuse homogeneously increased signal in-
tensity throughout the whole IPFP on fluid sensitive
sequences (Fig. 3), which was not observed in any of
the 20 HIV negative subjects.
The interaction between time and the HIV group was
significant for all fat pad parameters (Table 3), therefore
significant differences averaged over all timepoints were
not tested.
Discussion
This is the first longitudinal 3 T MRI study to evaluate
quantitatively and semi-quantitatively knee degenerative
changes and signal alteration of the IPFP and SPFP in
people living with HIV (PLWH) treated with ART. We
found that PLWH had higher global knee entropy T2
values averaged over all timepoints in the longitudinal
analysis, indicating a more heterogeneous and disor-
dered cartilage matrix composition. At baseline, we
found that the HIV group had significantly greater size
of IPFP signal abnormalities and higher signal intensity
of the SPFP. Moreover, PLWH had significantly higher
joint effusion scores at baseline and on average over all
timepoints compared to the control group.
Cartilage damage is the hallmark of knee OA, and car-
tilage matrix degeneration is an essential event that de-
termines the irreversible progression of knee OA [29].
To date, only one study reported that total body fat and
android fat were inversely associated with knee tibia car-
tilage volume in PLWH [16]. In our study, PLWH
showed a more heterogeneous and disordered cartilage
matrix composition in the longitudinal analysis of cartil-
age GLCM texture parameters. Interestingly, we did not
find any significant differences in WORMS cartilage
Fig. 2 Changes in subchondral cysts WORMS sum scores and effusion WORMS scores during the 96-month follow-up. a Changes in subchondral
cysts WORMS sum scores over 96 months. b Changes in effusion WORMS scores over 96 months. Data were given as adjusted means (scores),
corrected adjusted for age, sex, race and baseline BMI and K&L grades. Error bars represented standard errors. P-values in bold refer to significant
differences between groups on average over 8 years, respectively: subchondral cysts sum scores (P = 0.002) and effusion scores (P = 0.001)
Fig. 3 46-year-old HIV-infected man on ART with diffuse increased
signal intensity within infrapatellar fat pad. Sagittal intermediate-
weighted fat-suppressed image (TR/TE = 3200/30 ms, FOV = 16 cm,
slice thickness = 3mm) of the left knee in a 46-year-old HIV-infected
male on ART presented diffuse increased signal intensity within
infrapatellar fat pad (*), and to a lesser extent within suprapatellar fat
pad (arrow)
Liu et al. BMC Musculoskeletal Disorders          (2019) 20:190 Page 7 of 10
scores, indicating that findings in HIV infection may
predominantly affect the knee cartilage matrix. However
due to small sample size we may not have had enough
power to detect significant differences. The exact mech-
anism of cartilage degeneration in PLWH remains to be
elucidated. In the setting of HIV-related joint disease
there are at least two aspects worth considering: First,
the HIV-associated sarcopenia may reduce the strength
of muscle around the knee joint and affect the normal
knee joint biomechanics [30], which may promote cartil-
age degeneration. The fatty infiltration in the muscles
surrounding the knee joint may also be involved in the
alteration of muscle strength [4, 31]. Secondly, multiple
metabolic abnormalities associated with HIV, medica-
tions, and chronic inflammation have been reported to
have deleterious effects on cartilage metabolism, includ-
ing hypertension, hyperglycemia, lipodystrophy among
others [2, 4, 8, 13–15]. For example, subchondral ische-
mia resulting from hypertension may compromise the
nutrient exchange of cartilage, and hyperglycemia may
induce cartilage matrix stiffness, subchondral bone de-
struction and chondrocyte dysfunction [14]. To date, lit-
tle is known about whether HIV/ART can directly affect
chondrocytes and the cartilage matrix. However, consid-
ering that HIV was reported to be able to infect chon-
drocytes [32], the more direct association between HIV/
ART and cartilage matrix needs to be further explored.
Synovial inflammation can exacerbate cartilage degener-
ation by secreting more catabolic and pro-inflammatory
mediators [33]. In turn, cartilage breakdown products also
promote the inflammation of synovium [33, 34]. There is
evidence that synovitis can be present at all stages of knee
OA and is associated with cartilage destruction, knee pain
and the progression of knee OA [21, 33, 34]. IPFP signal
alteration and knee joint effusion have been reported to
be surrogate markers for synovitis on non-contrast MRI,
which were referred to as “Hoffa-synovitis” and “effusion--
synovitis” respectively [20, 21]. As a local adipose tissue,
abnormal IPFP and SPFP can secrete proinflammatory cy-
tokines and adipokines, and thus may aggravate the local
synovial inflammation [22, 35]. Studies have described the
MRI features of OA-associated Hoffa-synovitis, which
presents with distinguishable non-diffuse, heterogeneous
alteration in signal intensity, often involving characteristic-
ally discrete portions of the IPFP and/or surrounding
structures [17, 20–22]. In our study, two out of ten
HIV-infected subjects presented a diffuse and homoge-
neous increased signal intensity throughout the whole
IPFP, which was different from the imaging features of
OA-associated Hoffa-synovitis and was not observed in
the 20 HIV negative subjects. This special Hoffa-synovitis
has been confirmed to be a non-specific inflammation,
primarily composed of synovial proliferation and chronic
nonspecific perivascular inflammatory cell infiltration
[18]. The histological changes of SPFP signal alteration in
HIV positive individuals remains unclear. However, in pre-
vious knee OA studies have been reported that SPFP sig-
nal changes may be similar to that observed in the IPFP
which is characterized by inflammation, swelling, hyper-
trophy and fibrosis [23, 24]. Moreover, we found more se-
vere effusion-synovitis at all timepoints in PLWH
compared to controls. This difference likely results from
the chronic inflammatory status promoting the release of
proinflammatory mediators and could explain why
HIV-infected subjects had more severe Hoffa-synovitis
and SPFP synovitis at baseline.
Unexpectedly, the HIV group had a lower subchondral
cysts scores compared to HIV-negative controls. Cur-
rently, two theories have been proposed to explain the ori-
gin of subchondral cysts in knee OA. The “synovial fluid
intrusion theory” [36] posits that joint fluid intrudes into
the subchondral bone via the breached subchondral plate,
leading to the formation of cystic cavities. However, the
“bony contusion theory” [37] suggests that cysts are the
result of traumatic bone necrosis after impact of two op-
posing articular surfaces. Since HIV viral proteins have
previously been reported to enhance osteoclast activity
and inhibit osteoblast activity and certain ART combina-
tions are known to detrimentally affect bone structure
[38–40], our findings of lower subchondral cyst scores in
PLWH seem counter-intuitive. However, given the com-
plex effects of HIV and ART on bone resorption and bone
formation, additional mechanisms may be involved redu-
cing the development of subchondral cysts.
Our study has several limitations. First, the sample size
was small; however, this is, to the best of our knowledge,
the largest longitudinal study that has been performed
to date in subjects with HIV. Studies have reported gen-
der differences in knee OA and HIV infection [41–43].
However, due to the small sample size, we did not
analyze the gender differences on cartilage degeneration
and knee structural changes in HIV-infected subjects,
which needs to be explored in future studies with larger
sample sizes. Also, we evaluated the structural abnor-
malities using the WORMS scoring system which con-
tributed to a more detailed assessment of the knee
structural changes, but this system may not be sensitive
enough to monitor more subtle changes of cartilage
composition. Quantitative measurements can help us to
obtain more accurate and compositional information
which is necessary to further clarify the association be-
tween treated HIV infection and the progression of knee
OA and will be our future research direction. Moreover,
in this study we did not investigate the relationship be-
tween serum and synovial fluid biomarkers and their re-
lation to HIV and OA. Synovial fluid biospecimens were
not available in the OAI database. We previously investi-
gated the relationship between serum and imaging
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biomarkers in a larger cohort and only found weak rela-
tionships [44]. Because of the small number of subjects
we did not analyze these relationships in this study. Lar-
ger scale studies are required to investigate these bio-
markers in subjects with HIV and their relation to OA
in the future. Despite these limitations, we believe this
study is valuable and provides novel information on the
effects of HIV of knee joint degeneration.
Conclusions
Our study showed a more heterogeneous and disordered
cartilage matrix composition in PLWH on ART, suggest-
ing that treated HIV infection may accelerate the degen-
eration of the knee cartilage matrix. In addition,
compared with the HIV negative group, PLWH had sig-
nificantly more severe knee joint effusion over 8 years.
Moreover, at baseline PLWH had significantly more sig-
nal abnormalities of the IPFP and the SPFP, consistent
with more severe joint effusion and knee synovitis. Our
results suggest that treated HIV infection is associated
with compositional changes of the cartilage matrix and
increased knee joint inflammation, but findings appear
not to have a significant impact on structural knee
degeneration.
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